Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53

<div>Flowchart illustrating the process of identification and subsequent characterization of hypothetical anticancer bacteriocins from gut microbial species.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53 

Figure 1 | Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53 